Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolay Korokhov

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Vaccine|February 10, 2009
Lentiviral vectors for HIV disease prevention and treatmentFranck Lemiale, Nikolay Korokhov
Vaccine|January 7, 2010
Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunityBenyam Asefa, Nikolay Korokhov, Franck Lemiale
Vaccine|March 2, 2010
An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterizationFranck Lemiale, Benyam Asefa, Delia Ye, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Targeted and shielded adenovectors for cancer therapySusan J Hedley, Jian Chen, John D Mountz, et al.
Journal of Virology|June 5, 2009
The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelopeLuis M Agosto, Jianqing J Yu, Megan K Liszewski, et al.
Virus Research|November 19, 2005
Generation and selection of targeted adenoviruses embodying optimized vector propertiesSam C Noureddini, Alexander Krendelshchikov, Vera Simonenko, et al.
Molecular Pharmaceutics|June 7, 2005
A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate systemNikolay Korokhov, Sam C Noureddini, David T Curiel, et al.
Journal of Virology|September 5, 2008
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alphaMax W Richardson, Richard G Carroll, Matthew Stremlau, et al.
Human Vaccines & Immunotherapeutics|October 5, 2019
Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinomaJ Milburn Jessup, Mohamed Kabbout, Nikolay Korokhov, et al.
Journal of Virology|October 15, 2003
Genetically targeted adenovirus vector directed to CD40-expressing cellsNatalya Belousova, Nikolay Korokhov, Valentina Krendelshchikova, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Vaccine|February 10, 2009
Lentiviral vectors for HIV disease prevention and treatmentFranck Lemiale, Nikolay Korokhov
Vaccine|January 7, 2010
Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunityBenyam Asefa, Nikolay Korokhov, Franck Lemiale
Vaccine|March 2, 2010
An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterizationFranck Lemiale, Benyam Asefa, Delia Ye, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Targeted and shielded adenovectors for cancer therapySusan J Hedley, Jian Chen, John D Mountz, et al.
Journal of Virology|June 5, 2009
The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelopeLuis M Agosto, Jianqing J Yu, Megan K Liszewski, et al.
Virus Research|November 19, 2005
Generation and selection of targeted adenoviruses embodying optimized vector propertiesSam C Noureddini, Alexander Krendelshchikov, Vera Simonenko, et al.
Molecular Pharmaceutics|June 7, 2005
A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate systemNikolay Korokhov, Sam C Noureddini, David T Curiel, et al.
Journal of Virology|September 5, 2008
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alphaMax W Richardson, Richard G Carroll, Matthew Stremlau, et al.
Human Vaccines & Immunotherapeutics|October 5, 2019
Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinomaJ Milburn Jessup, Mohamed Kabbout, Nikolay Korokhov, et al.
Journal of Virology|October 15, 2003
Genetically targeted adenovirus vector directed to CD40-expressing cellsNatalya Belousova, Nikolay Korokhov, Valentina Krendelshchikova, et al.
Pageof 2